Citigroup’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-50,000
Closed -$2.4M 7829
2018
Q3
$2.4M Buy
+50,000
New +$2.05M ﹤0.01% 2566
2013
Q4
Sell
-50,000
Closed -$677K 7142
2013
Q3
$677K Buy
+50,000
New +$588K ﹤0.01% 3214

Other funds holding STAA

Citigroup's STAA Position: Q1 2026 in Review

Citigroup reduced its STAAR Surgical (STAA) stake by 30% in Q1 2026, selling an estimated $58.9K and leaving 7,049 shares worth $132K. The position accounts for ﹤0.01% of the portfolio, ranked #4182.

Citigroup first reported a position in STAA in Q2 2013 and has held it in 52 quarters since. The position peaked at $16.9M in Q3 2021. 187 funds tracked by Wall St. Rank hold STAA as of Q1 2026.

  • Citigroup held 7,049 shares of STAAR Surgical worth $132K as of Q1 2026.
  • Citigroup sold 3,086 STAAR Surgical shares in Q1 2026, an estimated $58.9K.
  • STAAR Surgical made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4182 holding.
  • Citigroup first reported a position in STAAR Surgical in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's STAAR Surgical position peaked at $16.9M in Q3 2021.
  • 187 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.